Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Terminated 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 1

Conditions

Glioblastoma 202Central Nervous System Neoplasms 122Brain Neoplasms 107Gliosarcoma 85Glioma 68Astrocytoma 63Oligodendroglioma 34Neuroblastoma 29Medulloblastoma 20Neoplasm Metastasis 19Carcinoma, Non-Small-Cell Lung 15Lung Neoplasms 14Ependymoma 11Diffuse Intrinsic Pontine Glioma 11Breast Neoplasms 11Meningeal Carcinomatosis 8Neoplasms 7Lymphoma 7Squamous Cell Carcinoma of Head and Neck 6Sarcoma 6Optic Nerve Glioma 6Neuroectodermal Tumors, Primitive 6Lymphoma, Follicular 6Head and Neck Neoplasms 6Esthesioneuroblastoma, Olfactory 6Burkitt Lymphoma 6Spinal Cord Neoplasms 5Salivary Gland Neoplasms 5Rhabdoid Tumor 5Recurrence 5

Interventions

Temozolomide 1Radiotherapy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Metatropic dwarfism × Radiotherapy × CNS × Clear all
NCT04324840 2024-07-26

A Study of CC-90010 in Combination With Temozolomide With or Without Radiation Therapy in Participants With Newly Diagnosed Glioblastoma

Celgene

Phase 1 Terminated
184 enrolled
CNS

Metatropic dwarfism, Glioblastoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡